Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

TCBP

TC BioPharm (TCBP)

TC BioPharm Holdings PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TCBP
일자시간출처헤드라인심볼기업
2025/02/2022:00PR Newswire (US)TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO ForumNASDAQ:TCBPTC BioPharm Holdings PLC
2025/02/1322:30PR Newswire (US)TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical TrialNASDAQ:TCBPTC BioPharm Holdings PLC
2025/02/1100:00PR Newswire (US)TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical TrialNASDAQ:TCBPTC BioPharm Holdings PLC
2025/02/0602:00PR Newswire (US)TCBP to Implement ADS Ratio ChangeNASDAQ:TCBPTC BioPharm Holdings PLC
2025/01/1522:30PR Newswire (US)TCBP Announces H5N1 Proof of Concept Studies IntentionNASDAQ:TCBPTC BioPharm Holdings PLC
2025/01/1322:45PR Newswire (US)TCBP to Present at Sequire Investor Summit 2025NASDAQ:TCBPTC BioPharm Holdings PLC
2025/01/0711:26PR Newswire (US)/C O R R E C T I O N -- TC BioPharm/NASDAQ:TCBPTC BioPharm Holdings PLC
2025/01/0703:30PR Newswire (US)TCBP Trading Continues Unabated on Nasdaq Stock ExchangeNASDAQ:TCBPTC BioPharm Holdings PLC
2025/01/0100:15PR Newswire (US)TCBP Provides Update on Acquisition Strategy and Current TargetsNASDAQ:TCBPTC BioPharm Holdings PLC
2024/12/3100:30PR Newswire (US)TCBP Issues 25% Stock DividendNASDAQ:TCBPTC BioPharm Holdings PLC
2024/12/2022:30PR Newswire (US)TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 PatientsNASDAQ:TCBPTC BioPharm Holdings PLC
2024/12/1822:30PR Newswire (US)TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder DividendNASDAQ:TCBPTC BioPharm Holdings PLC
2024/12/1121:00PR Newswire (US)TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyNASDAQ:TCBPTC BioPharm Holdings PLC
2024/12/0422:30PR Newswire (US)TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical TrialNASDAQ:TCBPTC BioPharm Holdings PLC
2024/11/1223:30PR Newswire (US)TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® GrantNASDAQ:TCBPTC BioPharm Holdings PLC
2024/10/3021:30PR Newswire (US)TCBP Provides Shareholder Update and Highlights Recent Milestone AchievementsNASDAQ:TCBPTC BioPharm Holdings PLC
2024/10/2522:45PR Newswire (US)TCBP Responds to False Social Media ClaimNASDAQ:TCBPTC BioPharm Holdings PLC
2024/10/2302:45AllPennyStocks.comBiotech Shares Rip Following Collaboration Announcement For Monkeypox ResearchNASDAQ:TCBPTC BioPharm Holdings PLC
2024/10/2221:30PR Newswire (US)TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticNASDAQ:TCBPTC BioPharm Holdings PLC
2024/10/0321:30PR Newswire (US)TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor ScreeningNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/2521:30PR Newswire (US)TCBP Announces Site Opening of Guys and St. Thomas HospitalNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/2421:45PR Newswire (US)TCBP to Present at the 2024 ThinkEquity Conference in NYCNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/2105:00PR Newswire (US)/C O R R E C T I O N -- TC BioPharm/NASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/1221:30PR Newswire (US)TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical TrialNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0921:30PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0705:00PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0521:30PR Newswire (US)TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TCBPTC BioPharm Holdings PLC
2024/09/0321:30PR Newswire (US)TCBP Announces Dosing of 5 New Patients in ACHIEVENASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/3104:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
2024/08/3006:11Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TCBPTC BioPharm Holdings PLC
 검색 관련기사 보기:NASDAQ:TCBP

최근 히스토리

Delayed Upgrade Clock